These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 63277)

  • 1. Effect of Ca++ on the stability of influenza virus neuraminidase.
    Baker NJ; Gandhi SS
    Arch Virol; 1976; 52(1-2):7-18. PubMed ID: 63277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in the divalent cation requirements of influenza a virus N2 neuraminidases.
    Johansson BE; Brett IC
    J Biochem; 2003 Sep; 134(3):345-52. PubMed ID: 14561719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of viral neuraminidases by an inhibitor, neuraminin, produced by Streptomyces sp.
    Lin W; Oishi K; Aida K
    Virology; 1977 May; 78(1):108-14. PubMed ID: 67704
    [No Abstract]   [Full Text] [Related]  

  • 4. Dependence of the activity of an influenza virus neuraminidase upon Ca2+.
    Dimmock NJ
    J Gen Virol; 1971 Dec; 13(3):481-3. PubMed ID: 4110613
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement and stabilization effect of EDTA on Sendai virus neuraminidase activity.
    Popa LM; Repanovici R
    Acta Virol; 1977 Jul; 21(4):280-7. PubMed ID: 71853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.
    Deshairs C; Kessler N; Aymard M; Quash GA
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():409-18. PubMed ID: 3950578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic acid is cleaved from glycoconjugates at the cell surface when influenza virus neuraminidases are expressed from recombinant vaccinia viruses.
    Els MC; Laver WG; Air GM
    Virology; 1989 May; 170(1):346-51. PubMed ID: 2718386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.
    Johansson BE; Pokorny BA; Tiso VA
    Vaccine; 2002 Feb; 20(11-12):1670-4. PubMed ID: 11858877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of neuraminidase from influenza C virus.
    Nerome K; Ishida M; Nakayama M
    Arch Virol; 1976; 50(3):241-4. PubMed ID: 56930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of ethylenediaminetetraacetate on various neuraminidases.
    Boschman TA; Jacobs J
    Biochem Z; 1965 Sep; 342(5):532-41. PubMed ID: 4956354
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the role of myxovirus neuraminidase in virus-cell receptors interaction by means of direct determination of sialic acid split from cells. I. Experiments on influenza virus-RBC cell system.
    Tsvetkova IV; Lipkind MA
    Arch Gesamte Virusforsch; 1968; 23(4):299-312. PubMed ID: 4971430
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuraminidase assay of influenza vaccines.
    Bevan AM; Furminger IG; Smith CH
    Dev Biol Stand; 1975; 28():173-80. PubMed ID: 1126567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of neuraminidases of the same subtype but from different species using a new method of titration.
    Fiszon B; Hannoun C
    J Virol Methods; 1990 Jan; 27(1):79-90. PubMed ID: 2307719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of influenza virus neuraminidases: peptide changes associated with antigenic divergence between early and late N2 neuraminidases.
    Kendal AP; Kiley MP
    J Virol; 1973 Dec; 12(6):1482-90. PubMed ID: 4761727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymological characteristics of avian influenza A virus neuraminidase.
    Kiyotani K; Takei N; Senoo M; Takao S; Otsuki K; Tsubokura M; Yoshida T
    Microbiol Immunol; 1987; 31(11):1131-5. PubMed ID: 2451112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.
    Kendal AP
    Virology; 1975 May; 65(1):87-99. PubMed ID: 49979
    [No Abstract]   [Full Text] [Related]  

  • 17. Purification of neuraminidase from influenza viruses by affinity chromatography.
    Bucher DJ
    Biochim Biophys Acta; 1977 Jun; 482(2):393-9. PubMed ID: 884122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic profile of neuraminidases of influenza A viruses isolated in 1957-1973.
    Luzyanina TY; Golubev DB; Ivanova NA; Grinbaum EB; Aptekareva MN; Vaitkiene VV; Rumel NB
    Acta Virol; 1974 Nov; 18(6):479-85. PubMed ID: 4141862
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete metal ion requirement of influenza virus N1 neuraminidases. Brief report.
    Carroll SM; Paulson JC
    Arch Virol; 1982; 71(3):273-7. PubMed ID: 6808973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the antigenicity of influenza virus neuraminidases due to various methods of preparation].
    Desselberger U
    Fortschr Med; 1978 Mar; 96(9):471-6. PubMed ID: 627393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.